Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts

Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
2626.35
0.15%
2626.35
0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 31st October 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsAudio-Q2FY2024.mp3 Written transcript of the same will be submitted in due course. This is for your information and records please.
2626.35
0.15%
Conference Call with Ajanta Pharma Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.
2626.35
0.15%
2626.35
0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 27th July 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsAudioQ1-2023-24.mp3 Written transcript of the same will be submitted in due course.
2626.35
0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our communication dated 5th May 2023 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 5th May 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link https://ajantapharma.com//images/EarningsCallTranscriptQ4(Jan-Mar)2022-23.pdf.
2626.35
0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 5th May 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EAC-Q4-(Jan-Mar)-2022-23.mp3 Written transcript of the same will be submitted in due course. This is for your information and records please.
2626.35
0.15%
Conference Call with Ajanta Pharma Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
2626.35
0.15%
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our communication dated 2nd February 2023 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 1st February 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsCallTranscriptQ3(Oct-Dec)2022-23.pdf
2626.35
0.15%

No results found

Earnings Calls Podcast on

mic under headphones